Authors:
MUNOZ M
RAYNAUD C
LANEELLE MA
JULIAN E
MARIN LML
SILVE G
AUSINA V
DAFFE M
LUQUIN M
Citation: M. Munoz et al., SEROREACTIVE SPECIES-SPECIFIC LIPOOLIGOSACCHARIDES OF MYCOBACTERIUM-MUCOGENICUM SP. NOV. (FORMERLY MYCOBACTERIUM CHELONAE-LIKE ORGANISMS) -IDENTIFICATION AND CHEMICAL CHARACTERIZATION, Microbiology, 144, 1998, pp. 137-148
Authors:
ORTALOMAGNE A
LEMASSU A
LANEELLE MA
BARDOU F
SILVE G
GOUNON P
MARCHAL G
DAFFE M
Citation: A. Ortalomagne et al., IDENTIFICATION OF THE SURFACE-EXPOSED LIPIDS ON THE CELL ENVELOPES OFMYCOBACTERIUM-TUBERCULOSIS AND OTHER MYCOBACTERIAL SPECIES, Journal of bacteriology, 178(2), 1996, pp. 456-461
Citation: Ma. Laneelle et al., STRUCTURES OF THE GLYCOLIPID ANTIGENS OF MEMBERS OF THE 3RD BIOVARIANT COMPLEX OF MYCOBACTERIUM-FORTUITUM, European journal of biochemistry, 238(1), 1996, pp. 270-279
Authors:
LOPEZMARIN LM
GAUTIER N
LANEELLE MA
SILVE G
DAFFE M
Citation: Lm. Lopezmarin et al., STRUCTURES OF THE GLYCOPEPTIDOLIPID ANTIGENS OF MYCOBACTERIUM-ABSCESSUS AND MYCOBACTERIUM-CHELONAE AND POSSIBLE CHEMICAL BASIS OF THE SEROLOGICAL CROSS-REACTIONS IN THE MYCOBACTERIUM-FORTUITUM COMPLEX, Microbiology, 140, 1994, pp. 1109-1118
Authors:
SILVE G
VALEROGUILLEN P
QUEMARD A
DUPONT MA
DAFFE M
LANEELLE G
Citation: G. Silve et al., ETHAMBUTOL INHIBITION OF GLUCOSE-METABOLISM IN MYCOBACTERIA - A POSSIBLE TARGET OF THE DRUG, Antimicrobial agents and chemotherapy, 37(7), 1993, pp. 1536-1538